New research shows that, in spite of recommendations discouraging use of aspirin in primary prevention of cardiovascular disease among older adults, nearly a third of adults 60 years and older are ...

Some seniors across the United States continue to take a daily aspirin in the hopes of reducing their cardiovascular disease risk, even though the practice is only recommended for certain high-risk ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. For cardiovascular disease, the best time to intervene would ideally be ...

Add Yahoo as a preferred source to see more of our stories on Google. Daily low-dose aspirin is no longer recommended for heart attack prevention for people 60 and over, but many still take it despite ...

Nat Clin Pract Cardiovasc Med. 2006;3(5):234-235. The rationale for prescribing aspirin to patients with or at risk of vascular disease is to try to reduce the risk of events that cause morbidity and ...

Aspirin with bottle Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events. Aspirin may prevent major adverse cardiovascular ...

A preliminary study found that adults with type 2 diabetes and a moderate or high risk of cardiovascular disease were less likely to experience a serious cardiovascular event when taking low-dose ...

Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary syndrome (CCS) who had prior stenting and were receiving long-term ...

Aspirin Bottle The use of aspirin was associated with a lower risk for cardiovascular events in individuals without cardiovascular disease. In individuals with no known cardiovascular disease (CVD), ...

August 30, 2009 (Barcelona, Spain) — The use of low-dose aspirin in the primary prevention of cardiovascular events in healthy individuals with asymptomatic atherosclerosis is currently not warranted, ...

The US Food and Drug Administration (FDA) on Monday said that it does not intend to take action against certain manufacturers of over-the-counter (OTC) aspirin products because the label includes ...